These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17432276)

  • 1. [Extrusion/spheronization: an important method for the production of the pellet dosage form].
    Häring A; Rabisková M
    Ceska Slov Farm; 2007 Jan; 56(1):11-6. PubMed ID: 17432276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of moistening on the extrusion and spheronization process].
    Rabisková M; Pérez JP
    Ceska Slov Farm; 2002 Sep; 51(5):244-7. PubMed ID: 12407923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H; Podczeck F; Newton JM
    Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline].
    Laicher A; Fuchs WS
    Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the formulation and process of Da Chuan Xiong Fang pellet by extrusion-spheronization].
    Hong YL; Feng Y; Xu DS; Jiang LH; Yang Y
    Zhong Yao Cai; 2007 Dec; 30(12):1596-600. PubMed ID: 18422197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.
    Kulkarni RB; Amin PD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):199-205. PubMed ID: 18302039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress relaxation test for the characterization of the viscoelasticity of pellets.
    Cespi M; Bonacucina G; Misici-Falzi M; Golzi R; Boltri L; Palmieri GF
    Eur J Pharm Biopharm; 2007 Sep; 67(2):476-84. PubMed ID: 17493792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the formulation parameters on the characteristics of pellets.
    Fekete R; Zelkó R; Marton S; Rácz I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of a flat die press for the manufacture of pharmaceutical pellets by extrusion/spheronization.
    Ghanam D; Kleinebudde P
    Drug Dev Ind Pharm; 2011 Apr; 37(4):456-64. PubMed ID: 21446830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pelletization of melts and liquids].
    Rabisková M
    Ceska Slov Farm; 2011 Apr; 60(2):54-60. PubMed ID: 21650006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation of a capsule preparation with high active ingredient content using re-crystallized drug compound].
    Angyal N; Terdy L; Varga Z; Akos K; Bódis A
    Acta Pharm Hung; 2004; 74(1):45-50. PubMed ID: 15524048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.
    Mallipeddi R; Saripella KK; Neau SH
    Saudi Pharm J; 2014 Sep; 22(4):360-72. PubMed ID: 25161381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A data mining approach to optimize pellets manufacturing process based on a decision tree algorithm.
    Ronowicz J; Thommes M; Kleinebudde P; Krysiński J
    Eur J Pharm Sci; 2015 Jun; 73():44-8. PubMed ID: 25835791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach.
    Varca GH; Lopes PS; Ferraz HG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):430-5. PubMed ID: 24410044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content.
    Mezreb N; Charrueau C; Boy P; Allain P; Chaumeil JC
    Drug Dev Ind Pharm; 2004 May; 30(5):481-90. PubMed ID: 15244083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach.
    Désiré A; Paillard B; Bougaret J; Baron M; Couarraze G
    Drug Dev Ind Pharm; 2013 Feb; 39(2):176-85. PubMed ID: 23216219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.